Clinical Research Directory
Browse clinical research sites, groups, and studies.
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Sponsor: Neurogen Biomarking LLC
Summary
This study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.
Key Details
Gender
All
Age Range
40 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2025-01-13
Completion Date
2026-08-01
Last Updated
2026-07-14
Healthy Volunteers
Yes
Locations (5)
Insigth Hospital and Medical Center Chicago
Chicago, Illinois, United States
Insight Hospital and Medical Center Dearborn
Dearborn, Michigan, United States
Insight Institute of Neurology and Neurosurgery
Flint, Michigan, United States
Memorial Healthcare Hospital
Owosso, Michigan, United States
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States